EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti-IL-17 Inhibits PINK1/Parkin Autophagy and M1 Macrophage Polarization in Rheumatic Heart Disease

Ling Bai, Yuan Li, Chuanghong Lu, Yiping Yang, Jie Zhang, Zirong Lu, Keke Huang, Shenglin Xian, Xi Yang, Na Na, Feng Huang, Zhiyu Zeng

Inflammation · 2024

DOI: 10.1007/s10753-024-02094-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inflammation, 2024. Verfasst von Ling Bai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Shuang Yong Road 6, Nanning, 530021, Guangxi, China. Hauptthemen laut MEDLINE: Autophagy, Interleukin-17, Rheumatic Heart Disease, Macrophages. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rheumatic heart disease (RHD) is an important and preventable cause of cardiovascular death and disability, but the lack of clarity about its exact mechanisms makes it more difficult to find alternative methods or prevention and treatment. We previously demonstrated that increased IL-17 expression plays a crucial role in the development of RHD-related valvular inflammatory injury. Macrophage autophagy/polarization may be a pro-survival strategy in the initiation and resolution of the inflammatory process. This study investigated the mechanism by which IL-17 regulates autophagy/polarization activation in macrophages. A RHD rat model was generated, and the effects of anti-IL-17 and 3-methyladenine (3-MA) were analyzed. The molecular mechanisms underlying IL-17-induced macrophage autophagy/polarization were investigated via in vitro experiments. In our established RHD rat model, the activation of the macrophage PINK1/Parkin autophagic pathway in valve tissue was accompanied by M1 macrophage infiltration, and anti-IL-17 treatment inhibited autophagy and reversed macrophage inflammatory infiltration, thereby attenuating endothelial–mesenchymal transition (EndMT) in the valve tissue. The efficacy of 3-MA treatment was similar to that of anti-IL-17 treatment. Furthermore, in THP-1 cells, the pharmacological promotion of autophagy by IL-17 induced M1-type polarization, whereas the inhibition of autophagy by 3-MA reversed this process. Mechanistically, silencing PINK1 in THP-1 blocked autophagic flux. Moreover, IL-17-induced M1-polarized macrophages promoted EndMT in HUVECs. This study revealed that IL-17 plays an important role in EndMT in RHD via the PINK1/Parkin autophagic pathway and macrophage polarization, providing a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyInterleukin-17Rheumatic Heart DiseaseMacrophagesProtein KinasesUbiquitin-Protein LigasesAnimalsRatsHumansTHP-1 CellsAdenineRats, Sprague-DawleyMacrophage ActivationMalePTEN-Induced Putative Kinase

Stichwörter der Autor:innen

autophagyil-17macrophagepink1/parkinpolarizationrheumatic heart disease

Substanzen

Interleukin-17Protein KinasesUbiquitin-Protein LigasesAdeninePTEN-Induced Putative Kinaseparkin protein3-methyladenine

Autor:innen und Institutionen

  • Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Shuang Yong Road 6, Nanning, 530021, Guangxi, China.
  • Guangxi Key Laboratory Base of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention, Guangxi Clinical Research Center for Cardio-Cerebrovascular Diseases, Nanning, Guangxi, China.
  • Department of Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
  • Emergency Office, Nanning Center for Disease Control and Prevention, Nanning , Guangxi, China.
  • Department of Endocrinology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
  • Department of Neuroscience, The Scripps Research Institute, La Jolla, USA.

Zitieren

APA

Bai, L., Li, Y., Lu, C., Yang, Y., Zhang, J., Lu, Z., Huang, K., Xian, S., Yang, X., Na, N., Huang, F., & Zeng, Z. (2024). Anti-IL-17 Inhibits PINK1/Parkin Autophagy and M1 Macrophage Polarization in Rheumatic Heart Disease. Inflammation. https://doi.org/10.1007/s10753-024-02094-3

Vancouver

Bai L, Li Y, Lu C, Yang Y, Zhang J, Lu Z, et al. Anti-IL-17 Inhibits PINK1/Parkin Autophagy and M1 Macrophage Polarization in Rheumatic Heart Disease. Inflammation. 2024. doi:10.1007/s10753-024-02094-3

BibTeX
@article{Bai2024,
  author = {Bai, Ling and Li, Yuan and Lu, Chuanghong and Yang, Yiping and Zhang, Jie and Lu, Zirong and Huang, Keke and Xian, Shenglin and Yang, Xi and Na, Na and Huang, Feng and Zeng, Zhiyu},
  title = {Anti-IL-17 Inhibits PINK1/Parkin Autophagy and M1 Macrophage Polarization in Rheumatic Heart Disease},
  journal = {Inflammation},
  year = {2024},
  doi = {10.1007/s10753-024-02094-3}
}
Kostenlos starten →